Variant report
Variant | nsv517950 |
---|---|
Chromosome Location | chr8:34797403-34803940 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs17249529 | chr8:34797403-34797404 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs372353893 | chr8:34797408-34797409 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs182062692 | chr8:34797443-34797444 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs530982608 | chr8:34797507-34797508 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs530976506 | chr8:34797512-34797513 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs138334901 | chr8:34797518-34797519 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs531392115 | chr8:34797560-34797561 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs549522121 | chr8:34797620-34797621 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs545719496 | chr8:34797642-34797643 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs570742693 | chr8:34797645-34797646 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs374563452 | chr8:34797721-34797722 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs146265483 | chr8:34797745-34797746 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs34789860 | chr8:34797748-34797749 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs376128807 | chr8:34797749-34797750 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs67956814 | chr8:34797756-34797757 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs75642511 | chr8:34797758-34797759 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs200756941 | chr8:34797761-34797762 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs534782376 | chr8:34797768-34797769 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs549169287 | chr8:34797849-34797850 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs143356680 | chr8:34797878-34797879 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs7002122 | chr8:34797886-34797887 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs561546299 | chr8:34797931-34797932 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs10105027 | chr8:34797942-34797943 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs535489778 | chr8:34797949-34797950 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs554814151 | chr8:34797969-34797970 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs547683957 | chr8:34797993-34797994 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs576426159 | chr8:34798033-34798034 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs537370957 | chr8:34798088-34798089 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs558771138 | chr8:34798113-34798114 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs577151401 | chr8:34798117-34798118 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs186088491 | chr8:34798120-34798121 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs557905831 | chr8:34798137-34798138 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs4415310 | chr8:34798167-34798168 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs113147621 | chr8:34798176-34798177 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs541479175 | chr8:34798198-34798199 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs371061646 | chr8:34798200-34798201 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs563613448 | chr8:34798249-34798250 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs190756249 | chr8:34798258-34798259 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs532992461 | chr8:34798336-34798337 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs148349769 | chr8:34798341-34798342 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs182609572 | chr8:34798394-34798395 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs373599691 | chr8:34798411-34798412 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs572966985 | chr8:34798427-34798428 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs369676522 | chr8:34798433-34798434 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs568475813 | chr8:34798470-34798471 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs529257551 | chr8:34798495-34798496 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs550677548 | chr8:34798538-34798539 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs569307210 | chr8:34798553-34798554 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs537334255 | chr8:34798565-34798566 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs188115515 | chr8:34798594-34798595 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16573809 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Prostate cancer | 21965145 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Lung cancer | 18438408 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Immune disease | 21572526 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Kallmann Syndrome 2 | 22470819 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Developmental delay | 21373258 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 17603634 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Melanoma | 20688739 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Breast cancer | 21806811 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Bladder cancer | 19088036 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Breast cancer | 20459607 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Colorectal cancer | 16912164 | CNVD |
Neuroticism | 17667963 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Breast cancer | 17001308 | CNVD |
Breast cancer | 17157792 | CNVD |
Cancer | 17001308 | CNVD |
Cancer | 18840272 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Chordoma | 18071362 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ductal carcinoma | 18381933 | CNVD |
Breast cancer | 21328542 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Intellectual disability | 22045946 | CNVD |
Lung cancer | 17925434 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Breast cancer | 16608533 | CNVD |
Breast cancer | 21364760 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:34796800-34797600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr8:34797200-34802000 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
3 | chr8:34797400-34798400 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr8:34797400-34802000 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
5 | chr8:34797400-34803800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr8:34798400-34798800 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
7 | chr8:34798400-34799000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
8 | chr8:34799000-34801200 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
9 | chr8:34801200-34804800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
10 | chr8:34801800-34803000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
11 | chr8:34801800-34803000 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
12 | chr8:34801800-34804400 | Enhancers | Cortex derived primary cultured neurospheres | brain |
13 | chr8:34802000-34802600 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
14 | chr8:34802000-34803200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
15 | chr8:34802000-34804400 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
16 | chr8:34802200-34802400 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
17 | chr8:34802200-34802600 | Enhancers | Brain Germinal Matrix | brain |
18 | chr8:34802200-34803000 | Enhancers | H1 Cell Line | embryonic stem cell |
19 | chr8:34802400-34804000 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
20 | chr8:34802600-34803800 | Weak transcription | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
21 | chr8:34803000-34804000 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
22 | chr8:34803800-34804400 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
23 | chr8:34803800-34804600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |